Protein Biomarkers Dengue Vaccine

Posters Jun 9, 2018
Infectious Diseases
|
Proteomics

June 9, 2018

V. Hindie¹, P. Croteau¹, S. Aziri¹, S. Lo¹, J. Sui¹, L. Cortes¹, E. Kallas², R.P. Sekaly³, and E. Paramithiotis¹. ¹Caprion Biosciences Inc, Montreal, QC, Canada. ²School of Medicine, University of Sao Paulo, Sao Paulo, Brazil. ³Case Western Reserve University, Cleveland, OH, USA. VH, PC, SA, SL, JS, LC, and EP are employees of Caprion Biosciences Inc.

Protein Biomarkers Predictive of Multivalent Response to a Novel Dengue Vaccine, European Congress of Immunology, 2018

Protein biomarkers predictive of multivalent response to a novel dengue vaccine

Featured Resources

See All Experts' Insights
WRIB 2 Posters
Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS
SITC Poster Posters
Oct 30, 2025

Combining high-plex proteomics with single-cell transcriptomics for deep characterization of antigen-specific T cell responses
AACR 2025 Posters
Apr 27, 2025

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?
See All Experts' Insights

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Talk to our Team
cta banner